Patents by Inventor Jeffery S. Loutit

Jeffery S. Loutit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF AEROSOLIZED LEVOFLOXACIN FOR TREATING CYSTIC FIBROSIS
    Publication number: 20210228589
    Abstract: Methods for treating cystic fibrosis. The method includes administering to a human in need thereof an aerosol solution comprising levofloxacin or ofloxacin and a divalent or trivalent cation. More particularly, the method includes administering the aerosol solution to a human having a pulmonary infection comprising P. aeruginosa.
    Type: Application
    Filed: August 28, 2020
    Publication date: July 29, 2021
    Inventors: Jeffery S. LOUTIT, Elizabeth E. MORGAN, Michael N. DUDLEY, David C. GRIFFITH, Olga LOMOVSKAYA
  • Use of aerosolized levofloxacin for treating cystic fibrosis
    Patent number: 10792289
    Abstract: Methods for treating cystic fibrosis. The method includes administering to a human in need thereof an aerosol solution comprising levofloxacin or ofloxacin and a divalent or trivalent cation. More particularly, the method includes administering the aerosol solution to a human having a pulmonary infection comprising P. aeruginosa.
    Type: Grant
    Filed: January 31, 2019
    Date of Patent: October 6, 2020
    Assignee: Horizon Orphan LLC
    Inventors: Jeffery S. Loutit, Elizabeth E. Morgan, Michael N. Dudley, David C. Griffith, Olga Lomovskaya
  • USE OF AEROSOLIZED LEVOFLOXACIN FOR TREATING CYSTIC FIBROSIS
    Publication number: 20200000817
    Abstract: Methods for treating cystic fibrosis. The method includes administering to a human in need thereof an aerosol solution comprising levofloxacin or ofloxacin and a divalent or trivalent cation. More particularly, the method includes administering the aerosol solution to a human having a pulmonary infection comprising P. aeruginosa.
    Type: Application
    Filed: January 31, 2019
    Publication date: January 2, 2020
    Inventors: Jeffery S. LOUTIT, Elizabeth E. MORGAN, Michael N. DUDLEY, David C. GRIFFITH, Olga LOMOVSKAYA
  • Use of aerosolized levofloxacin for treating cystic fibrosis
    Patent number: 10231975
    Abstract: Methods for treating cystic fibrosis. The method includes administering to a human in need thereof an aerosol solution comprising levofloxacin or ofloxacin and a divalent or trivalent cation. More particularly, the method includes administering the aerosol solution to a human having a pulmonary infection comprising P. aeruginosa.
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: March 19, 2019
    Assignee: Horizon Orphan LLC
    Inventors: Jeffery S. Loutit, Elizabeth E. Morgan, Michael N. Dudley, David C. Griffith, Olga Lomovskaya
  • USE OF AEROSOLIZED LEVOFLOXACIN FOR TREATING CYSTIC FIBROSIS
    Publication number: 20180085376
    Abstract: Methods for treating cystic fibrosis. The method includes administering to a human in need thereof an aerosol solution comprising levofloxacin or ofloxacin and a divalent or trivalent cation. More particularly, the method includes administering the aerosol solution to a human having a pulmonary infection comprising P. aeruginosa.
    Type: Application
    Filed: June 14, 2017
    Publication date: March 29, 2018
    Inventors: Jeffery S. Loutit, Elizabeth E. Morgan, Michael N. Dudley, David C. Griffith, Olga Lomovskaya
  • Use of aerosolized levofloxacin for treating cystic fibrosis
    Patent number: 9700564
    Abstract: Methods for treating cystic fibrosis. The method includes administering to a human in need thereof an aerosol solution comprising levofloxacin or ofloxacin and a divalent or trivalent cation. More particularly, the method includes administering the aerosol solution to a human having a pulmonary infection comprising P. aeruginosa.
    Type: Grant
    Filed: March 5, 2012
    Date of Patent: July 11, 2017
    Assignee: Horizon Orphan LLC
    Inventors: Jeffery S. Loutit, Elizabeth E. Morgan, Michael N. Dudley, David C. Griffith, Olga Lomovskaya
  • ALTERING PHARMACOKINETICS OF PIRFENIDONE THERAPY
    Publication number: 20140221434
    Abstract: The invention relates to methods for reducing adverse events in patients receiving pirfenidone (5-methyl-1-phenyl-2-(1H)-pyridone) therapy.
    Type: Application
    Filed: April 7, 2014
    Publication date: August 7, 2014
    Applicant: INTERMUNE, INC.
    Inventors: Cynthia Y. Robinson, Jeffery S. Loutit, Michelle M. Freemer
  • USE OF AEROSOLIZED LEVOFLOXACIN FOR TREATING CYSTIC FIBROSIS
    Publication number: 20120276153
    Abstract: Methods for treating cystic fibrosis. The method includes administering to a human in need thereof an aerosol solution comprising levofloxacin or ofloxacin and a divalent or trivalent cation. More particularly, the method includes administering the aerosol solution to a human having a pulmonary infection comprising P. aeruginosa.
    Type: Application
    Filed: March 5, 2012
    Publication date: November 1, 2012
    Applicant: MPEX PHARMACEUTICALS, INC.
    Inventors: Jeffery S. Loutit, Elizabeth E. Morgan, Michael N. Dudley, David C. Griffith, Olga Lomovskaya
  • Use of Aerosolized Antibiotics for Treating Chronic Obstructive Pulmonary Disease
    Publication number: 20120237564
    Abstract: The present invention relates to methods and compositions for treating obstructive pulmonary disorders. In particular, compositions and methods described herein relate to the use of an aerosolized antibiotic for treating obstructive pulmonary disorders including chronic obstructive pulmonary disorder (COPD) and chronic bronchitis (CB).
    Type: Application
    Filed: February 16, 2012
    Publication date: September 20, 2012
    Applicant: MPEX Pharmaceuticals, Inc.
    Inventors: Michael N. Dudley, Neil Berkley, David C. Griffith, Jeffery S. Loutit, Elizabeth E. Morgan, Keith A. Bostian, Sanjay Sethi
  • Altering Pharmacokinetics of Pirfenidone Therapy
    Publication number: 20110136876
    Abstract: The invention relates to methods for reducing adverse events in patients receiving pirfenidone (5-methyl-1-phenyl-2-(1H)-pyridone) therapy.
    Type: Application
    Filed: February 16, 2011
    Publication date: June 9, 2011
    Applicant: INTERMUNE, INC.
    Inventors: Cynthia Y. Robinson, Jeffery S. Loutit, Michelle M. Freemer
  • ALTERING PHARMACOKINETICS OF PIRFENIDONE THERAPY
    Publication number: 20080287508
    Abstract: The invention relates to methods for reducing adverse events in patients receiving pirfenidone (5-methyl-1-phenyl-2-(1H)-pyridone) therapy.
    Type: Application
    Filed: January 25, 2008
    Publication date: November 20, 2008
    Applicant: INTERMUNE, INC.
    Inventors: Cynthia Y. Robinson, Jeffery S. Loutit, Michelle M. Freemer